{"url_path":"/sec/traw/8-k/2026-07-09/cover-page","section_key":"cover-page","section_title":"Cover Page","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-09","source_url":"https://www.sec.gov/Archives/edgar/data/1130598/0001104659-26-082250-index.html","accession_number":"0001104659-26-082250","cik":"0001130598","ticker":"TRAW","issuer_name":"Traws Pharma, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1130598/0001104659-26-082250-index.html","primary_entity_key":"0001130598","primary_entity_name":"Traws Pharma, Inc."},"word_count":310,"has_tables":true,"body_markdown":"false\n0001130598\n\n0001130598\n\n2026-07-08\n2026-07-08\n\niso4217:USD\n\nxbrli:shares\n\niso4217:USD\n\nxbrli:shares\n\n \n\n \n\n \n\n**UNITED STATES**\n\n**SECURITIES AND EXCHANGE COMMISSION**\n\n**Washington, DC 20549**\n\n \n\n**FORM 8-K**\n\n \n\n**CURRENT REPORT**\n\n**PURSUANT TO SECTION 13 OR 15(d) OF\nTHE**\n\n**SECURITIES EXCHANGE ACT OF 1934**\n\n \n\nDate of Report (Date of earliest event reported):\nJuly 8, 2026\n\n \n\n**Traws\nPharma, Inc.**\n\n(Exact name of Registrant as specified in its\ncharter)\n\n \n\n**Delaware**\n \n**001-36020**\n \n**22-3627252**\n\n(State or Other Jurisdiction\n\nof Incorporation or Organization)\n \n(Commission\n\nFile Number)\n \n(I.R.S. Employer\n\nIdentification No.)\n\n \n\n**12 Penns Trail**\n\n**Newtown, PA 18940**\n\n**(267****)\n759-3680**\n\n(Address,\nIncluding Zip Code, and Telephone Number, Including Area Code, of Registrant’s Principal Executive Offices)\n\n \n\n**Not Applicable**\n\n(Former name or former address, if changed since\nlast report)\n\n \n\nCheck the appropriate box below if the Form 8-K\nis intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:\n\n \n\n¨Written\ncommunications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)\n\n \n\n¨Soliciting\nmaterial pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)\n\n \n\n¨Pre-commencement\ncommunications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))\n\n \n\n¨Pre-commencement\ncommunications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))\n\n \n\nSecurities registered pursuant to Section 12(b) of the Act:\n\n \n\n**Title of each class**\n**Trading Symbol(s)**\n**Name of each exchange on which registered**\n\nCommon\nstock, par value $.01 per share\nTRAW\nThe\nNasdaq Stock Market LLC\n\n \n\nIndicate by check mark whether the registrant\nis an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2\nof the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).\n\n \n\nEmerging growth company  ¨\n\n \n\nIf\nan emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying\nwith any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨"}